Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(20):1502-1503; doi:10.1093/jnci/95.20.1502
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Illman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Illman, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

NEWS

New Charity Chief Discusses His Fast-Paced Agenda

John Illman

The first 10% of the full text of this article appears below.

When Paul Nurse, Ph.D., left his post earlier this year as chief executive of Cancer Research U.K., to become president of Rockefeller University in New York, there was much speculation about who would replace him as head of the world’s largest independent cancer research charity. So, many insiders were surprised at the appointment of Alex Markham, M.D., Ph.D., a relative unknown in the cancer research community.


Figure Removed (Available Only in the Full Text)
View larger version (197K):
[in this window]
[in a new window]
  		Alex Markham, M.D., Ph.D., was appointed chief executive of Cancer Research U.K. He took over the position in September.

 
His low profile will not last long. No other developed country depends on charity to fund cancer research as much as the United Kingdom. Between 1959 and 1979, the U.K. Charity Commission registered 340 new charities to promote medical knowledge and . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?